HCA Healthcare (HCA) Earnings Analysis

HCA Healthcare (HCA) next reports earnings on 2026-07-24, consensus EPS 7.56 USD. Last quarter (2026-04-24) it beat with EPS 7.15 USD vs 7.12 USD est (+0.4%). It has beaten estimates in 8/8 recent quarters (100%). Trailing P/E 12.71.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does HCA next report earnings?

Next earnings date2026-07-24
Consensus EPS estimate7.56 USD
Revenue estimate19.76B

HCA earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-04-247.15 USD7.12 USD+0.4%Beat
2026-01-278.01 USD7.46 USD+7.4%Beat
2025-10-246.96 USD5.79 USD+20.2%Beat
2025-07-256.84 USD6.29 USD+8.7%Beat
2025-04-256.45 USD5.75 USD+12.2%Beat
2025-01-246.22 USD6.13 USD+1.5%Beat
2024-10-255.03 USD4.99 USD+0.8%Beat
2024-07-235.53 USD4.85 USD+14%Beat

Beat rate: 8/8 (100%) over reported quarters with consensus data.

HCA valuation and analyst view

Trailing P/E12.71
Trailing EPS29.975 USD
Price / book-13.37
Dividend yield0.81%
Market cap82.70B
Analyst consensusBuy (29 buy / 15 hold / 2 sell)
Avg price target470.89 USD

Related research pages

Frequently asked questions

When is HCA Healthcare (HCA)'s next earnings date?

HCA Healthcare is next scheduled to report on 2026-07-24, with a consensus EPS estimate of 7.56 USD and revenue estimate of 19.76B.

Did HCA beat earnings last quarter?

In its 2026-04-24 report, HCA posted EPS of 7.15 USD versus a 7.12 USD estimate — a beat of 0.4%.

What is HCA's earnings track record?

Over the last 8 reported quarters with consensus data, HCA beat estimates 8 times (100%).

What is HCA's current P/E ratio and EPS?

HCA trades at a trailing P/E of 12.71 on trailing EPS of 29.975336748245116 USD.

What do analysts rate HCA?

Analyst consensus is "Buy" across 46 ratings (0 strong buy, 29 buy, 15 hold, 2 sell, 0 strong sell). Average 12-month price target: 470.89 USD.